BioInvent International AB (BINV) — Capital Reinvestment Ratio
Latest as of June 2025:
0.02x
BioInvent International AB (BINV) has a Capital Reinvestment Ratio of 0.02x as of June 2025, meaning it reinvests 0% of its operating cash flow (Skr66.78 Million) in capital expenditures (Skr1.38 Million). See BINV FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.02x
Capex / Operating Cash Flow
Operating Cash Flow
Skr66.78 Million
SEK
Capital Expenditures
Skr1.38 Million
SEK
Data as of
Jun 2025
Most recent filing
BioInvent International AB Capital Reinvestment Ratio (2007–2008)
This chart tracks BioInvent International AB's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for BioInvent International AB (2007–2008)
Year-by-year Capital Reinvestment Ratio for BioInvent International AB from 2007 to 2008. For live market cap and broader valuation context, see market cap of BioInvent International AB.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2008 | 0.31x | Skr43.73 Million | Skr13.64 Million | ▲ +0.8% |
| 2007 | 0.31x | Skr12.63 Million | Skr3.91 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow